Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person PCNA is SUMOylated with SUMO1 at lysine-164, lysine-254, and...
| Class:Id | Summation:4615897 |
|---|---|
| _displayName | PCNA is SUMOylated with SUMO1 at lysine-164, lysine-254, and... |
| _timestamp | 2015-03-08 13:36:16 |
| created | [InstanceEdit:4615844] May, B, 2013-09-27 |
| modified | [InstanceEdit:5228461] May, B, 2014-01-11 [InstanceEdit:5678245] May, Bruce, 2015-02-23 [InstanceEdit:5682545] May, Bruce, 2015-03-08 |
| text | PCNA is SUMOylated with SUMO1 at lysine-164, lysine-254, and other residues (Papouli et al. 2005, Pfander et al. 2005, Gali et al. 2012, Impens et al. 2014). SUMO1 is predominant in vivo. SUMOylation prevents double strand break formation and recombination if DNA replication stalls at lesions (Gali et al. 2012). This is comparable to the situation in Saccharomyces cerevisiae where sumoylated PCNA recruits the Srs2 helicase to prevent recombination during S phase (Pfander et al. 2005, Papouli et al. 2005). In the yeast PCNA homolog, SUMO at lysine-164 is located on the opposite face of PCNA from the face that interacts with DNA polymerase (Freudenthal et al. 2011). |
| (summation) | [Reaction:4615910] SUMOylation of PCNA with SUMO1 [Homo sapiens] |
| [Change default viewing format] | |
No pathways have been reviewed or authored by PCNA is SUMOylated with SUMO1 at lysine-164, lysine-254, and... (4615897)
